Eli Lilly becomes first drugmaker to get GLP-1 weight-loss pill approved in China
- China approved Eli Lilly's weight-loss pill, orforglipron, making it the first approved GLP-1 pill in the country.
- Once-daily pill helps reduce appetite & control blood sugar, offering an alternative to weight-loss injections.
- • Eli Lilly will compete with Novo Nordisk, Pfizer & Chinese drugmaker Innovent Biologics in China's obesity treatment market.
- Company has not announced the pill's price or launch date in China, despite receiving regulatory approval.
Source: google.com
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android



